| Market Cap | Rp 33.48 T |
| P/E Ratio | 9.30× |
| P/BV | 1.38× |
| ROE | 14.77% |
| Profit Margin | 9.57% |
| Div. Yield | 265.00% |
| EPS | 79.58 |
| DER | 3.21× |
| Beta | -0.07 |
| 52W High | Rp 1,345 |
| 52W Low | Rp 630 |
PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business, and E-health products. In addition, the com...
PT Kalbe Farma Tbk. (KLBF) diperdagangkan di Rp 740 (-1.99%), sektor Kesehatan. Update otomatis 17.00 WIB setelah penutupan pasar BEI.
RSI (14) di 41.9 — zona netral. MACD bearish, tren: DOWNTREND. Volume 0.05× rata-rata.
Sinyal PrismaAI: SELL. Untuk analisa lengkap 12 komponen, MTF, Smart Money — daftar gratis di PrismaAI.
Harga KLBF (PT Kalbe Farma Tbk.) tercatat Rp 740 (-1.99%). Data diperbarui pukul 17.00 WIB setiap hari kerja.
Sinyal algoritma PrismaAI untuk KLBF saat ini adalah SELL. Ini bukan saran investasi — selalu lakukan riset mandiri (DYOR) dan konsultasikan dengan penasihat keuangan Anda.
PT Kalbe Farma Tbk. (KLBF) adalah perusahaan yang terdaftar di Bursa Efek Indonesia (BEI) dalam sektor Kesehatan. PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Con
Sinyal AI real-time, Multi-Timeframe, Smart Money flow, portofolio tracker — gratis dicoba.